|
Proteintech
dhrs2 ![]() Dhrs2, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dhrs2+antibody/pmc12979117-98-13-14?v=Proteintech Average 92 stars, based on 1 article reviews
dhrs2 - by Bioz Stars,
2026-07
92/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
dhrs2 antibody ![]() Dhrs2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dhrs2+antibody/pmc05389036-242-1-7?v=Santa+Cruz+Biotechnology Average 85 stars, based on 1 article reviews
dhrs2 antibody - by Bioz Stars,
2026-07
85/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
anti-dhrs2 primary antibody ![]() Anti Dhrs2 Primary Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dhrs2+antibody/pm32058041-100-35-40?v=ABclonal+Biotechnology Average 90 stars, based on 1 article reviews
anti-dhrs2 primary antibody - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Rabbit Polyclonal Anti DHRS2 Antibody
|
Buy from Supplier |
|
The DHRS2 Antibody from Novus is a DHRS2 antibody to DHRS2. This antibody reacts with Human. The DHRS2 antibody has been validated for the following applications: Immunohistochemistry, Immunohistochemistry-Paraffin.
|
Buy from Supplier |
|
Displays NADPH-dependent dicarbonyl reductase activity in vitro with 3,4-Hexanedione, 2,3-Heptanedione and 1-Phenyl-1,2-propanedione as substrates. No reductase activity is displayed in vitro with steroids, retinoids and sugars as substrates. Attenuates MDM2-mediated p53/TP53 degradation, leading to p53/TP53
|
Buy from Supplier |
|
Displays NADPH-dependent dicarbonyl reductase activity in vitro with 3,4-Hexanedione, 2,3-Heptanedione and 1-Phenyl-1,2-propanedione as substrates. No reductase activity is displayed in vitro with steroids, retinoids and sugars as substrates. Attenuates MDM2-mediated p53/TP53 degradation, leading to p53/TP53
|
Buy from Supplier |
|
This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) family, which has over 46,000 members. Members of this family are enzymes that metabolize many different compounds, such as steroid hormones, prostaglandins, retinoids, lipids and
|
Buy from Supplier |
|
Displays NADPH-dependent dicarbonyl reductase activity in vitro with 3,4-Hexanedione, 2,3-Heptanedione and 1-Phenyl-1,2-propanedione as substrates. No reductase activity is displayed in vitro with steroids, retinoids and sugars as substrates. Attenuates MDM2-mediated p53/TP53 degradation, leading to p53/TP53
|
Buy from Supplier |
|
Displays NADPH-dependent dicarbonyl reductase activity in vitro with 3,4-Hexanedione, 2,3-Heptanedione and 1-Phenyl-1,2-propanedione as substrates. No reductase activity is displayed in vitro with steroids, retinoids and sugars as substrates. Attenuates MDM2-mediated p53/TP53 degradation, leading to p53/TP53
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Immunology
Article Title: Mitochondrial dysfunction and immune microenvironment in gestational diabetes mellitus: insights from bioinformatics analysis and experimental validation
doi: 10.3389/fimmu.2026.1771616
Figure Lengend Snippet: Single-cell resolution reveals the expression of hub mitochondrial-related genes (Mito-RGs) and the immune landscape in gestational diabetes mellitus (GDM). (A) Uniform manifold approximation and projection (UMAP) plot presenting distinct cell clusters identified from single-cell RNA sequencing (scRNA- seq ) data. (B) UMAP plot displaying the distribution of cells across different individual samples, including GDM and control groups. (C) UMAP plot comparing cell distributions between GDM and control groups. (D) Bubble plot highlighting the top five marker genes for each cell cluster, aiding in the identification of major cell types. (E) UMAP plot with annotated cell types, including tissue stem cells, epithelial cells, macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, endothelial cells, myelocytes, and common myeloid progenitors (CMPs). (F) Bar plot illustrating the proportions of different identified cell types in each sample. (G) Bar plot comparing the proportions of major cell types between the GDM and control groups. (H) Feature plots depicting the expression patterns of hub Mito-RG (DHRS2, STX17, and TIMM44) in specific cell clusters. (I) Feature plot showing the distribution of Mito-RGs scores across various cell subpopulations, reflecting their enrichment in particular immune and stromal cell types.
Article Snippet: Overnight incubation of tissue sections at 4 °C was performed with primary antibodies:
Techniques: Single Cell, Expressing, RNA Sequencing, Control, Marker
Journal: Frontiers in Immunology
Article Title: Mitochondrial dysfunction and immune microenvironment in gestational diabetes mellitus: insights from bioinformatics analysis and experimental validation
doi: 10.3389/fimmu.2026.1771616
Figure Lengend Snippet: Cell-cell communication analysis and experimental validation of hub mitochondrial-related genes (Mito-RGs) expression. (A) Heatmap of gene set variation analysis (GSVA) enrichment across different cell subtypes. (B) Cell-cell communication network diagram illustrating interactions among various cell subtypes. (C-E) Ligand-receptor pair analysis of key signaling pathways: (C) TGFB1-TGFBR1/TGFBR2, (D) FN1-ITGA5/ITGB1, and (E) LAMA5-CD44. (F) Comparison of body weight changes between gestational diabetes mellitus (GDM) and control mice. (G) Comparison of blood glucose levels between GDM and control mice at different time points during the oral glucose tolerance test (OGTT). (H-J) Immunohistochemistry (IHC) staining and scoring of DHRS2 (H) , STX17 (I) , and TIMM44 (J) in placental tissues from GDM and control mice.
Article Snippet: Overnight incubation of tissue sections at 4 °C was performed with primary antibodies:
Techniques: Biomarker Discovery, Expressing, Protein-Protein interactions, Comparison, Control, Immunohistochemistry
Journal: Scientific Reports
Article Title: Apoptosis Signal-regulating Kinase 1 promotes Ochratoxin A-induced renal cytotoxicity
doi: 10.1038/srep08078
Figure Lengend Snippet: Proteins differentially expressed in response to OTA treatment versus control in Scrambled shRNA cell group (118:117). Shading area indicates proteins that also appeared in ASK1 knockdown cell group. Proteins are ordered alphabetically by their gene names
Article Snippet: The
Techniques: Control, shRNA, Knockdown
Journal: Scientific Reports
Article Title: Apoptosis Signal-regulating Kinase 1 promotes Ochratoxin A-induced renal cytotoxicity
doi: 10.1038/srep08078
Figure Lengend Snippet: Proteins differentially expressed in response to OTA treatment versus control in ASK1 knockdown cell group (121:119). Shading area indicates proteins that also appeared in scrambled cell group. Proteins are ordered alphabetically by their gene names
Article Snippet: The
Techniques: Control, Knockdown
Journal: Scientific Reports
Article Title: Apoptosis Signal-regulating Kinase 1 promotes Ochratoxin A-induced renal cytotoxicity
doi: 10.1038/srep08078
Figure Lengend Snippet: Four proteins were selected to validate the alteration trend using Western Blot. Gels were run under the same experimental conditions while images of western blots displayed in cropped format. KRT18 was up-regulated in ASK1 knockdown cell group and PKM was up-regulated in scrambled cell group compared with control (no drug treatment). CDK1 and DHRS2 were both down-regulated in scrambled cell group as well as ASK1 knockdown cell group compared to control. Actin was used as a loading control.
Article Snippet: The
Techniques: Western Blot, Knockdown, Control